The Patent Finder

Methods of Treating Ovarian Cancer

Tesaro, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/US2017/040039, filed Jun 29, 2017. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,383,542Methods of Treating Ovarian Cancer
In force
 · High confidence
Tesaro, Inc.In force
High confidence
US 12,527,780Methods of Treating Ovarian Cancer
In force
 · High confidence
Tesaro, Inc.In force
High confidence
Application 17/652,422Methods of Treating Ovarian Cancer
Abandoned
Abandoned Oct 6, 2023
Tesaro, Inc.AbandonedAbandoned Oct 6, 2023
Application 17/652,443Methods of Treating Ovarian Cancer
Abandoned
Abandoned Jan 3, 2023
Tesaro, Inc.AbandonedAbandoned Jan 3, 2023
Application 17/652,457Methods of Treating Ovarian Cancer
Abandoned
Abandoned Apr 24, 2023
Tesaro, Inc.AbandonedAbandoned Apr 24, 2023
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Tesaro, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited